Skip to main navigation Skip to search Skip to main content

Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania

  • Aida Abdraimova
  • , Stéphane Besançon
  • , Jill Portocarrero
  • , Kaushik Ramaiya
  • , Asel Dunganova
  • , Margaret Ewen
  • , Hans Hogerzeil
  • , Maria Lazo-Porras
  • , Richard Laing
  • , Molly Lepeska
  • , Happy Nchimbi
  • , Assa Sidibé
  • , Andrew Swai
  • , Janeth Tenorio-Mucha
  • , John S. Yudkin
  • , Jessica H. Zafra-Tanaka
  • , Aida Zurdinova
  • , David Beran
  • Health Policy Analysis Centre
  • Santé Diabète
  • Universidad Peruana Cayetano Heredia
  • Hindu Mandal Hospital
  • Tanzanian Diabetes Association
  • Health Action International
  • University Medical Center Groningen
  • University of Geneva
  • Boston University School of Public Health
  • University of Western Cape
  • Tanzanian NCD Alliance
  • Hôpital du Mali
  • University College London
  • Ministry of Health

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Aims: To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Peru and Tanzania. Methods: The Rapid Assessment Protocol for Insulin Access, a multi-level assessment of the health system, was implemented in Kyrgyzstan, Mali, Peru and Tanzania using document reviews, site visits and interviews to assess the delivery of care and access to insulin. Results: Despite the existence of noncommunicable or diabetes strategies and Universal Health Coverage policies including diabetes-related supplies, this has not necessarily translated into access to insulin or diabetes care for all. Insulin and related supplies were often unavailable and unaffordable. Across the four countries test strips and insulin, when paid for by the individual, represented respectively 48–82% and 25–36% of total costs. Care was mainly delivered at tertiary-level hospitals by specialists. Only Kyrgyzstan had data collection systems integrated into the Ministry of Health structure. In addition, issues with healthcare worker training and education and empowerment of people with diabetes were present in these health systems. Conclusions: People with type 1 diabetes in these countries face different barriers, including the cost of insulin and care. Given the renewed attention to diabetes on the global health agenda tailored health system responses for type 1 diabetes are needed. Insulin should be prioritized as it is the foundation of type 1 diabetes care, but other elements of care and support need to be fostered by different actors.

Original languageEnglish
Article numbere14891
JournalDiabetic Medicine
Volume39
Issue number8
DOIs
StatePublished - Aug 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Keywords

  • developing countries
  • health delivery of health care
  • insulin
  • type 1 diabetes

Fingerprint

Dive into the research topics of 'Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania'. Together they form a unique fingerprint.

Cite this